Free and Cued Selective Reminding Test (16-words) Turkish Adaptation Study (SIHT-16)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05756231|
Recruitment Status : Completed
First Posted : March 6, 2023
Last Update Posted : March 6, 2023
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease||Intervention/treatment||Phase|
|Dementia Memory Impairment||Behavioral: SIHT-16||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||270 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Free and Cued Selective Reminding Test (16-words) Turkish Adaptation Study|
|Actual Study Start Date :||January 5, 2020|
|Actual Primary Completion Date :||January 26, 2023|
|Actual Study Completion Date :||February 20, 2023|
Experimental: Turkish Adaptation Study of Free and Cued Selective Reminding Test (SIHT-16)
Outcomes of Turkish adaptation of Free and cued selective reminding test (SIHT-16) is compared with memory and non-memory test in three alternative lists: a,b, and c parallel lists. The participants are assessed in neurological diagnosis routine.
a pencil-paper assessment tool.
- Validity of translation [ Time Frame: once ]Variances of answers given to each form will be compared to each other to know if they are similar or different.
- Factor Analyses [ Time Frame: once ]Factor Analyses must be conducted to redefine the weight of each item on measuring memory deficits to be sure that turkish words version is similar to original factor weights.
- Validity of the ability of the measure to objectify the memory deficit in dementia [ Time Frame: once ]Test measures must be sensitive enough to objectify a memory deficits even in early stages of dementia. The scores of memory test in early and late stages of dementia will be compared to see if they are different. It's expected to be different.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||Child, Adult, Older Adult|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||Yes|
- having memory complaints
- demanding clinical consultation for the memory complaint
- vascular pathology
- extrapyramidal findings
- psychiatric illness
- cognition affecting drug use
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05756231
|Istanbul, Turkey, 34340|
|Study Director:||İ. Hakan Gürvit, Prof. MD.||Istanbul University|
|Responsible Party:||Jbid DURSUN UNCU, Clinical Neuropsychologist, Istanbul University|
|Other Study ID Numbers:||
|First Posted:||March 6, 2023 Key Record Dates|
|Last Update Posted:||March 6, 2023|
|Last Verified:||February 2023|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||No|
Free and Cued Selective Reminding Test
Central Nervous System Diseases
Nervous System Diseases